4//SEC Filing
ROBIN HOWARD W 4
Accession 0000950170-24-138693
CIK 0000906709other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 9:08 PM ET
Size
7.8 KB
Accession
0000950170-24-138693
Insider Transaction Report
Form 4
ROBIN HOWARD W
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2024-12-17$1.01/sh−46,995$47,465→ 1,195,710 total - Sale
Common Stock
2024-12-18$0.99/sh−85,035$84,185→ 1,110,675 total
Holdings
- 410(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.
- [F2]This transaction was executed in multiple trades at prices ranging from $1.00 to $1.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
- [F3]This transaction was executed in multiple trades at prices ranging from $.93 to $1.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
Documents
Issuer
NEKTAR THERAPEUTICS
CIK 0000906709
Entity typeother
Related Parties
1- filerCIK 0001206869
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 9:08 PM ET
- Size
- 7.8 KB